BioCentury
ARTICLE | Clinical News

Techniclone International Corp. regulatory update

July 22, 1996 7:00 AM UTC

TCLN received notice of allowance for a European patent covering its modified antibody technology (MAT), used to enhance the effectiveness of monoclonal antibodies. MAT involves attaching a small orga...